SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: jopawa who wrote (649)12/1/1998 1:23:00 PM
From: Dan Spillane  Read Replies (1) | Respond to of 2539
 
...isn't it also true that during these reviews there are "experts" who testify from competing pharmaceutical companies, with the interest of seeing the drugs NOT approved? Ha ha, which company does our "Mr. Reuters Story" represent?

Actually it is the duty of the news to correctly report stories in context and Reuters has a nack for not doing that. But as I pointed out, such news is FREE.



To: jopawa who wrote (649)12/1/1998 1:30:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 2539
 
John, now why would Searle CEO stick his neck out and say all those warm, fuzzy things to Dow Jones? As Dan says, Reuters is free and Reuters headlines appear on most of the quote service. The immediate reaction is sell. Last time I looked, the ask size is still much greater than the bid size.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News